Report Detail
Global (United States, European Union and China) Infectious Vaccines Market Research Report 2019-2025
- RnM3669400 |
- 14 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
A vaccine is a medical product primarily designed to stimulate antibodies against an infectious disease which help to improve the immunity of the target body.
Rising consumer awareness regarding health coupled with rising disposable income is expected to propel demand for infectious vaccines over the next seven years. Furthermore, increasing government activities to control epidemic diseases such as polio, camp fever, and swine flu is projected to have impact market growth significantly over the next seven years.
In 2019, the market size of Infectious Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Infectious Vaccines.
This report studies the global market size of Infectious Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Infectious Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
Market Segment by Product Type
Preventive vaccine
Therapeutic vaccine
Market Segment by Application
Adults
Pediatrics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Infectious Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Infectious Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Infectious Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Infectious Vaccines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Preventive vaccine
- 1.3.3 Therapeutic vaccine
- 1.4 Market Segment by Application
- 1.4.1 Global Infectious Vaccines Market Share by Application (2019-2025)
- 1.4.2 Adults
- 1.4.3 Pediatrics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Infectious Vaccines Market Size
- 2.1.1 Global Infectious Vaccines Revenue 2014-2025
- 2.1.2 Global Infectious Vaccines Sales 2014-2025
- 2.2 Infectious Vaccines Growth Rate by Regions
- 2.2.1 Global Infectious Vaccines Sales by Regions 2014-2019
- 2.2.2 Global Infectious Vaccines Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Infectious Vaccines Sales by Manufacturers
- 3.1.1 Infectious Vaccines Sales by Manufacturers 2014-2019
- 3.1.2 Infectious Vaccines Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Infectious Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Infectious Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Infectious Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.3 Infectious Vaccines Price by Manufacturers
- 3.4 Key Manufacturers Infectious Vaccines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Infectious Vaccines Market
- 3.6 Key Manufacturers Infectious Vaccines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Preventive vaccine Sales and Revenue (2014-2019)
- 4.1.2 Therapeutic vaccine Sales and Revenue (2014-2019)
- 4.2 Global Infectious Vaccines Sales Market Share by Type
- 4.3 Global Infectious Vaccines Revenue Market Share by Type
- 4.4 Infectious Vaccines Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Infectious Vaccines Sales by Application
6 United States
- 6.1 United States Infectious Vaccines Breakdown Data by Company
- 6.2 United States Infectious Vaccines Breakdown Data by Type
- 6.3 United States Infectious Vaccines Breakdown Data by Application
7 European Union
- 7.1 European Union Infectious Vaccines Breakdown Data by Company
- 7.2 European Union Infectious Vaccines Breakdown Data by Type
- 7.3 European Union Infectious Vaccines Breakdown Data by Application
8 China
- 8.1 China Infectious Vaccines Breakdown Data by Company
- 8.2 China Infectious Vaccines Breakdown Data by Type
- 8.3 China Infectious Vaccines Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Infectious Vaccines Breakdown Data by Company
- 9.2 Rest of World Infectious Vaccines Breakdown Data by Type
- 9.3 Rest of World Infectious Vaccines Breakdown Data by Application
- 9.4 Rest of World Infectious Vaccines Breakdown Data by Countries
- 9.4.1 Rest of World Infectious Vaccines Sales by Countries
- 9.4.2 Rest of World Infectious Vaccines Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 CSL Limited (Australia)
- 10.1.1 CSL Limited (Australia) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.1.4 Infectious Vaccines Product Introduction
- 10.1.5 CSL Limited (Australia) Recent Development
- 10.2 Bavarian Nordic (Denmark)
- 10.2.1 Bavarian Nordic (Denmark) Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.2.4 Infectious Vaccines Product Introduction
- 10.2.5 Bavarian Nordic (Denmark) Recent Development
- 10.3 GlaxoSmithKline plc. (U.K.)
- 10.3.1 GlaxoSmithKline plc. (U.K.) Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.3.4 Infectious Vaccines Product Introduction
- 10.3.5 GlaxoSmithKline plc. (U.K.) Recent Development
- 10.4 Emergent Bio Solutions Inc. (U.S.)
- 10.4.1 Emergent Bio Solutions Inc. (U.S.) Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.4.4 Infectious Vaccines Product Introduction
- 10.4.5 Emergent Bio Solutions Inc. (U.S.) Recent Development
- 10.5 MedImmune LLC (U.S.)
- 10.5.1 MedImmune LLC (U.S.) Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.5.4 Infectious Vaccines Product Introduction
- 10.5.5 MedImmune LLC (U.S.) Recent Development
- 10.6 Johnson and Johnson (U.S.)
- 10.6.1 Johnson and Johnson (U.S.) Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.6.4 Infectious Vaccines Product Introduction
- 10.6.5 Johnson and Johnson (U.S.) Recent Development
- 10.7 Novartis AG (Switzerland)
- 10.7.1 Novartis AG (Switzerland) Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.7.4 Infectious Vaccines Product Introduction
- 10.7.5 Novartis AG (Switzerland) Recent Development
- 10.8 Merck and Company (U.S.)
- 10.8.1 Merck and Company (U.S.) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.8.4 Infectious Vaccines Product Introduction
- 10.8.5 Merck and Company (U.S.) Recent Development
- 10.9 Sanofi Pasteur (France)
- 10.9.1 Sanofi Pasteur (France) Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.9.4 Infectious Vaccines Product Introduction
- 10.9.5 Sanofi Pasteur (France) Recent Development
- 10.10 Pfizer Inc. (U.S.)
- 10.10.1 Pfizer Inc. (U.S.) Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Infectious Vaccines
- 10.10.4 Infectious Vaccines Product Introduction
- 10.10.5 Pfizer Inc. (U.S.) Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Infectious Vaccines Sales Channels
- 11.2.2 Infectious Vaccines Distributors
- 11.3 Infectious Vaccines Customers
12 Market Forecast
- 12.1 Global Infectious Vaccines Sales and Revenue Forecast 2019-2025
- 12.2 Global Infectious Vaccines Sales Forecast by Type
- 12.3 Global Infectious Vaccines Sales Forecast by Application
- 12.4 Infectious Vaccines Forecast by Regions
- 12.4.1 Global Infectious Vaccines Sales Forecast by Regions 2019-2025
- 12.4.2 Global Infectious Vaccines Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Infectious Vaccines. Industry analysis & Market Report on Infectious Vaccines is a syndicated market report, published as Global (United States, European Union and China) Infectious Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Infectious Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
